Patented Products 
  Oncology Formulations
  Therapeutic
    
Segments
 Oncology API
  Specialty APIs
  Chiral intermediates
 
Oncology API 
KLab has a dedicated oncology facility for manufacturing various APIs. KLab also has a separate sterile powder manufacturing facility. The API dossier's available are equivalent to CTD (Europe), DMF (US) standards subject to site approvals. KLab has got WHO GMP/ cGMP / ISO 14001 / ISO 9001 and GLP certifications.
 
 
ANTI NEOPLASTIC CAS NO
Anastrazole IP / USP 120511-73-1
Bicalutamide USP 90357-06-5
Bortezomib IHS 179324-69-7
Capacitabine IP / USP 154361-50-9
Carboplatin BP / USP41575-94-4
Cisplatin IP / BP/ USP15663-27-1
Cyclophosphamide (Sterile / NON STERILE)
IP / BP / USP / EP
6055-19-2
Erlotinib hydrochloride IHS183319-69-9
Gefitinib IP/IHS 184475-35-2
Gemcitabine Hydrochloride BP / USP 95058-81-4
Hydroxyurea BP / USP 127-07-1
Imatinib Mesylate IP / IHS220127-57-1
Letrozole BP / USP 112809-51-5
Methotrexate I P / USP6745-93-3
Tamoxifen Citrate IP / BP / USP 54965-24-1
Zolendronic acid IP / IHS 118072-93-8
* IHS : In House Standard
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.